Patoz, Marie-Camille
Hidalgo-Mazzei, Diego
Pereira, Bruno
Blanc, Olivier
de Chazeron, Ingrid
Murru, Andrea
Verdolini, Norma
Pacchiarotti, Isabella
Vieta, Eduard
Llorca, Pierre-Michel
Samalin, Ludovic
Funding for this research was provided by:
Ministère des Affaires Sociales, de la Santé et des Droits des Femmes (PREPS 17-0121)
Article History
Received: 13 January 2021
Accepted: 1 April 2021
First Online: 3 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Pacchiarotti has received CME-related honoraria, or consulting fees from ADAMED, Janssen-Cilag and Lundbeck. Dr. Murru has served as a consultant, adviser or speaker for Adamed, AstraZeneca, Bristol-Myers Squibb, Janssen-Cilag, Lundbeck, Otsuka and Sanofi-Aventis and has received a grant (PI19/00672) from the Instituto de Salud Carlos IIISubdirección General de Evaluación y Fomento de la investigación, Plan Nacional 2019–2022. Prof. Vieta has received grants and served as a consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, Allergan, Angelini, AstraZeneca, Bristol-Myers Squibb, Dainippon Sumitomo Pharma, Farmindustria, Ferrer, Forest Research Institute, Gedeon Richter, Glaxo-Smith-Kline, Janssen, Lundbeck, Otsuka, Pfizer, Roche, SAGE, Sanofi-Aventis, Servier, Shire, Sunovion, Takeda, the Brain and Behaviour Foundation, the Spanish Ministry of Science and Innovation (CIBERSAM), the EU Horizon 2020 and the Stanley Medical Research Institute. Prof. Llorca has received grants, honoraria or consulting fees from ESAI, Gedeon Richeter, Janssen, Lundbeck, Otsuka and Sanofi. Dr. Samalin has received grants, honoraria or consulting fees from AstraZeneca, Bristol-Myers Squibb, Janssen-Cilag, Lundbeck, Otsuka, Sanofi-Aventis, and Takeda. The other authors declare that they have no conflicts of interest.